The weekly litigation news digest is live. Subscribe now

IP Verse

Hiv Treatment Formulation Of Atazanavir And Cobicistat - EP3054926

The patent EP3054926 was granted to Bristol Myers Squibb Ireland on Jul 25, 2018. The application was filed on Oct 6, 2014 under application number EP14786421A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3054926

BRISTOL MYERS SQUIBB IRELAND
Application Number
EP14786421A
Filing Date
Oct 6, 2014
Status
Granted And Under Opposition
Jun 22, 2018
Publication Date
Jul 25, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSApr 24, 2019BESTWITHDRAWN

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5849911
DESCRIPTIONUS8148374
INTERNATIONAL-SEARCH-REPORTUS2010178339
INTERNATIONAL-SEARCH-REPORTWO2009084036
INTERNATIONAL-SEARCH-REPORTWO2011127244
OPPOSITIONWO2011127244

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents